NDC59417-0975-71: ASPIRIN DELAYED-RELEASE TABLETS.
ASPIRIN DELAYED-RELEASE TABLETS. Key specifications include coating_feature: FILM, ENTERIC, features_provided: CHILD RESISTANT CLOSURE, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 100.000 TABLETS, active_medicament_medicinal_strength: 975.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-152-1983, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| coating_feature | FILM, ENTERIC |
| features_provided | CHILD RESISTANT CLOSURE |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 100.000 TABLETS |
| active_medicament_medicinal_strength | 975.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT |
| part_name_assigned_by_controlling_agency | ASPIRIN DELAYED RELEASE TABLETS USP 0.975 GRAM 100S G |
| NSN | 6505-01-152-1983 |
| COATING FEATURE | FILM, ENTERIC |
| PRIMARY CONTAINER CONTENT QUANTITY | 100.000 TABLETS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | CHILD RESISTANT CLOSURE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | ASPIRIN DELAYED RELEASE TABLETS USP 0.975 GRAM 100S G |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 975.000 MILLIGRAMS ASPIRIN ACTIVE INGREDIENT |